Skip Navigation
Skip to contents

ICDM 2018

Plenary lectures

Plenary lecture 1 11:10~11:50 / Friday 12 October
Convention hall A, B, C
Chairman: TBD
Overview
Dr. Barbara B. Kahn is Professor of Medicine, Harvard Medical School and vice chair for research strategy, department of medicine, Beth Israel Deaconess Medical Center. Dr. Kahn’s research has delved into understanding the critical role of the adipocyte as an endocrine organ and led to the discovery of novel adipocyte-secreted molecules such as RBP4 that is linked to insulin resistance and to the risk for T2D and cardiovascular disease in humans. She is best known for establishing a critical role for the AMP-activated protein kinase pathway in leptin action in both the hypothalamus and peripheral tissues. She received 2016 Banting Award from the American Diabetes Association and was elected to the US National Academy of Sciences in 2017. In ICDM 2018, She will deliver a lecture entitled “Novel class of signaling lipids with beneficial metabolic effects” based on her scientific journey.
Barbara B. Kahn
Harvard University, USA
Barbara B. Kahn
PL1 Novel class of signaling lipids with beneficial metabolic effects
Plenary lecture 2 A. 11:20-12:00 / Saturday 13 October
Convention hall A, B, C
Chairman: TBD
Overview
Prof. Philipp Scherer is the director of the Touchstone Diabetes Center at the University of Texas Southwestern Medical Center. Prof. Scherer’s research has delved into the integrated physiology of the adipocyte and the impact on whole body energy homeostasis, inflammation and cancer. He is best known for the identification of adipocyte-derived factors (adipokines). And he cloned adiponectin and has implicated the downstream signaling of adiponectin in the regulation of carbohydrate and lipid metabolism as well as the roles of adiponectin in cancer cell growth and survival. He has received numerous awards, including the 2015 Banting Award for Outstanding Scientific Achievement and 2012 J. Dennis McGarry Award by the American Diabetes Association. In ICDM 2018, he will deliver a lecture entitled “The adipocyte: a key target for diabetes research” based on his scientific journey.
Philipp E. Scherer
UT Southwestern Medical Center, USA
Philipp E. Scherer
PL2 The adipocyte: a key target for diabetes research